Dr. Ratner is a board-certified gynecologic oncologist specializing in ovarian malignancies. She co-founded Yale Medicine’s Sexuality, Intimacy and Menopause Program (SIMS) — one of the first in the country for cancer survivors — and directs Yale’s Early Ovarian Cancer Detection Program. Her research focuses on personalized chemotherapy and reversing chemo resistance, and her honors include the Yale Cancer Center Award for Clinical Excellence. She is also Co-Founder and Chief Medical Officer of MAT Designation.